Key action I: Food, nutrition and health

1
Key action I Food, nutrition and health

• RTD objectives
• safe/flexible and new/improved manuf. processes
  and technologies
• tests to detect and processes to eliminate
  infectious toxic agents.
• research into the role of food in promoting and
  sustaining health

• Societal aims
• to produce a safe, healthy, balanced and varied
  food supply for consumers
• to improve quality and consumer acceptability
• to reduce diet-related risk factors in chronic
  disease

2
Key Action 1 Food, Nutrition and Health
290 million Euro

• 1.1 Safe and flexible manufacturing processes and
  technologies

1.2 Detection and elimination of infectious and
toxic agents throughout the food chain
1.3 Role of food in promoting and sustaining
health
3
Key Action 1 Food, Nutrition and Health
Analytical laboratories
Agricultural sector
Policy
Medical doctors public health authorities
Food industry
Consumers
Food and nutrition scientists in universities and
research institutes
Retail sector
Restaurants and caterers
4
Philosophy of Key Action 1
Raw materials Process chain
Food technologies Food packaging Food distributio
n
Consumer nutrition Healthy diet Healthy
lifestyle
Well- being Health
5
Safe and Flexible ManufacturingProcesses and
Technologies

• Research Priorities for 2000
• Novel and improved biological raw materials for
  high quality food
• Advanced and optimised food technologies,
  packaging systems and process control
• Quality monitoring and traceability throughout
  the food chain

6
Detection and Elimination of Infectiousand Toxic
Agents throughout the Food Chain

• Research Priorities for 2000
• Improved understanding and control of
  contamination conditions along the entire food
  chain
• Rapid detection tests particularly for pathogens
  and hormones
• New and safer methods of food production and
  distribution
• New methodologies for assessing microbial,
  chemical and allergenic risks and exposures

7
Role of Foodin Promoting and Sustaining Health

• Research Priorities for 2000
• Consumer needs, attitudes and responses with
  regard to food products, food processing and
  labelling
• Role and impact of food on physiological
  functions, physical and mental performance
• Particular nutritional needs of defined
  population groups
• Links between diet and chronic diseases and
  disorders including the genetic factors involved

8
Comparison 1st and 2nd deadlines 1999

• June 99 November 99
• Nutrition/ Raw materials/
  Safety Processing/ Safe food prod.
• Roadmap indicated amount 62 M 26 M
• Response eligible proposals 181 209
• Requested contribution 371 M 317 M
• Average request 2.05 M 1.6 M
• Average n of participants 9.9 8.6
• To stage 2 (success rate) 67 (37) 55
  (26)
• Main priority list 39 (3 res.) 23
• Average EC contribution 1.8 M 1.4 M
• Success rate (stage 2) 58 42
• Industrial participation 29 50

9
Room for Improvement in KA 1
Advanced technologies, e.g. high
pressure, electric field pulses (1.1.2)
Traditional process technologies, e.g cheese
making, meat (1.1.1)
Packaging (1.1.2)
Quality management systems (1.1.3)
Consumer aspects (1.3.1)
Proposals
Vertical cooperation the food chain (1.1.3)
Catering (1.2.3)
10
KA1 Underpins Current and FutureEuropean Policies
Competitiveness Industrial penetration 96
Industrial participation 50
Consumer safety Gelatin and TSE Raw milk
cheeses Mycotoxin Rapid methods
White paper on food safety Traceability Hygienic
manufacturing Contaminants Novel foods
Consumer health Diseases and disorders Functional
Foods
KA 1
European food authority Scientific advice e.g.
hazards Information gathering e.g.
mycotoxins Communication-consumers e.g.
nutritionally enhanced food
Common fisheries policies Quality / added
value By-products Traceability Certification of
quality
11
Genetically modified foods-Cluster
QLK1-1999-00527/00651/00765/01182/01301

• Partnership Cluster of 4 Shared-Cost projects
  and 1 Network
• Total Cost 12.302.449 EUR EC
  Contribution 8.390.776 EUR
• Partners 53
• 12 universities (2 AT, BE, 3 DE, DK, 2 FI, 3 UK)
• 30 research centres (2 BE, AT, 2 DE, DK, ES, 2
  EU, 7 FR,
• IT, 4 NL, 2 NO, SE, 6 UK)
• 10 companies (BE, CH, DE, FR, 2 GR, NL, 3 UK)
• 1 consumer group (BE)
• Objectives
• To develop a communication platform of
  producers of GMOs, scientists, retailers,
  regulatory authorities and consumer groups
• To improve safety assessment procedures, risk
  management strategies and risk communication

12
Key action II Control of infectious diseases

• RTD objectives
• development of improved or novel vaccines,
  especially against viral diseases, including
  support of clinical trials.
• new / improved strategies to identify and control
  infectious diseases, directed at treatment
  prevention.
• public health and care-delivery systems, notably
  management, prevention and surveillance aspects

• Societal aims
• to combat established, emerging or re-emerging
  infectious diseases, both in humans and animals.
  
• to improve quality of life through improved
  prevention and treatment
• to reduce healthcare costs to society

13
KA2 CONTROL OF INFECTIOUS DISEASES 2.1
Vaccine development

• Issues for the new work programme
• 1. Mobilization of other stakeholders besides
  industry, in particular clinicians and public
  health professionals
• 2. Develop strategies to increase innovative
  potential by attracting new groups
• 3. Address evaluation of candidate vaccines in
  early phase clinical trials by means of
  demonstration projects
• 4. Stronger involvement of newly associated
  Eastern European countries

14
Key action III The Cell Factory

• RTD objectives
• new and innovative health-care processes and
  products (eg diagnostics, antibiotics,
  anti-cancer agents).
• energy-efficient bio-remediation and waste
  bio-treatment processes.
• new biological processes and products, new
  processing technologies using micro-organisms,
  plants and animals for agri-food and
  agro-industry and high value-added chemical
  applications.

• Societal aims
• helping EU companies exploit the advances made in
  life sciences, to develop products, processes
  and services with high added-value capable of
  enhancing the quality of life and health.
• to prevent, detect, monitor, treat and remove
  pollution, as well as to maximise the economic
  value of waste

15
KA3 The Cell Factory

• Whats different from FP4 ?
• In FP4, one of the evaluation criteria was to
  consider whether or not proposals were in the
  scope of the scientific fields, as described in
  the work programme.
• In FP5, this is replaced by whether or not
  proposals fit to the socioeconomic objective of
  the key action, as described in the work
  programme.

16
KA3 The Cell Factory

• The European Challenges
• Excellent sciences but disappointing
  exploitation.
• European weakness in terms of small
  research-based biotechnology firms.
• Underexploited reservoir of industrial
  competitiveness, ST innovation, opportunities
  for investors, and jobs creation.
• New integrated (as opposed to sequential)
  innovation process. Many new technologies are
  designed by young companies that did not exist 10
  years ago.

17
KA3 The Cell Factory

• Ways to tackle the problems
• Help the Communitys enterprises, either
  established or starting up, to generate and
  exploit advances in life sciences and
  technologies.
• Combine innovative technology platforms with
  industrial innovation.
• Good science is necessary but not sufficient,
  knowledge transfer and exploitation commitment is
  essential.

18
KA3 The Cell Factory

• Deliverables
• Enhanced competitiveness of knowledge-based
  industries
• Improved therapeutic arsenal for health care
• Improved environmental sustainability
• Improved quality in food, agro-industry and fine
  chemicals

19
KA3 The Cell Factory

• RTD Priorities
• Projects must combine innovative technology with
  industrial innovation strategy (e.g. existing
  industries, start ups, entrepreneurial
  initiatives).
• Projects should mobilise players from different
  categories (e.g. research, industry, finance, end
  users).
• Reasonable flexibility will be applied to the RTD
  fields to be mobilised (not described in
  extenso), provided projects focus on the above
  requirements and on the socio-economic objectives
  of the key action.

20
KA 3 The Cell Factory

• Selected RTD Priorities
• 3.1 New and innovative health-related processes
  and products
• Diagnostics (e.g. near-patient diagnostic tests)
• Therapeutic substances (e.g. drug discovery,
  antibiotics)
• Therapeutic strategies - gene therapy - tissue
  and cell engineering (e.g. DNA therapies)
• New and improved technologies for biological
  productions (e.g. plant based production
  systems)
• Novel in vitro testing as alternatives to animal
  testing (e.g. in vitro toxicity tests)

21
KA 3 The Cell Factory

• Selected RTD Priorities
• 3.2 Energy - efficient bioremediation and waste
  biotreatment processes
• New bioprocesses for preventing pollution (e.g.
  novel biocatalysts)
• Bioassays and biosensors (e.g. to assay the level
  of pollution)
• Biodegradation of recalcitrants chemical (e.g. to
  make more efficient biodegradation processes)
• Biodiversity and ecological dynamics of natural
  and introduced populations (e.g. development of
  biopesticides, ecological impact of transgenic
  plants)
• Methods and strategies for identifying GMOs

22
KA 3 The Cell Factory

• Selected RTD Priorities
• 3.3 New biological processes and products from
  cell factories
• Exploiting the cellular and molecular
  characteristics(e.g. nanobiotechnology for
  biomolecules self assembly)
• High value-added products/processes
  involving/derived from micro-organisms, plants
  and animals (e.g. more efficient
  bio-transformation)
• Functional biomolecules and biocatalysts (e.g. to
  develop biomolecules of utmost specificity)
• Identification and sustainable use of metabolic
  and genetic diversity as a source of new valuable
  products (e.g. screening
• methods of marines and terrestrial organisms).

23
Key action IV Environment and Health

• RTD objectives
• research into diseases and allergies related to
  the environment
• new methods of diagnosis, risk assessment and of
  processes.

• Societal aims
• treatment prevention of diseases and allergies
• to reduce the adverse impact of environment on
  health.

24
Key action V Sustainable agriculture, fisheries
and forestry, and integrated development of rural
areas, including mountain areas.

• RTD objectives
• new / improved systems of production and
  exploitation in agriculture, fisheries and
  aquaculture, including multi-functional
  management of forests
• integrated production and exploitation of
  biological materials for non-food uses.
• new tools and models for the integrated and
  sustainable development of rural and other
  relevant areas.

• Societal aims
• competitiveness,
• sustainable management of resources,
• product quality (food and non-food)
• employment
• support to evolving common policies.
• scientific basis for regulations and standards

25
KA5 sustainable agriculture, fisheries and
forestry, and integrated development of rural
areas, including mountain areas.

• Objectives
• Competitiveness
• Diversification
• Sustainable management and utilisation of
  biological resources
• Respond to societal demands for products
  complying with consumer well being and quality
  requirements

26
KA5 Sustainable agriculture, fisheries and
forestry, and integrated development of rural
areas, including mountain areas.

• Research areas
• New and sustainable systems of production
  (plants, animals, fish...)
• Integrated production and exploitation of
  biological materials for non-food user
• Sustainable and multi-purpose utilisation of
  forest resources the integrated forestry-wood
  chain
• Support for common policies
• New tools and models for integrated and
  sustainable development of rural and other
  relevant areas

27
5.3.2 The Forestry-Wood Chain - Priority list
15 Projects selected
.
Key Action Deliverables
Variability of European Spruce
(1520) Linking raw material character-
istics with industrial needs (1467)
Genetic determinism of maritime pine
properties (942) Fibre and wood properties in
poplar (1209) Information tools for efficient
forestry-wood chain (1477) Eco-efficient
harvesting (991)
Integrated systems of sustainable production
.
Clean and efficient transformation processes and
recycling technologies
Oxigen delignification (1277) Management of
water process systems (1389) Recycling of waste
lignocellulosic material (1221) Air emissions
in kraft pulp mills (1105) Upgrading recycled
fibres (1071)

• Delivery of new or improved
• products with
• high value added
• lower impact on environment
• health and safety requirements

.
Dry toner digital print/paper (929) Magnetic
resonance imaging of wood (1587)
Environmentally sound methods for pitch control
(1357) Wood-based panels in construction (1640)
28
Key Action 5 - Area 5.4.1, 5.4.2 Support for
Common policies - Common Agricultural Policy
5 proposals funded
Enlargement to CEECs - integrated rural
development in CEECs (1526) - Sustainable
agriculture in CEECs (1611)
Relevant KA Deliverables
Tools to foster, assess, measure and monitor
competitiveness of agriculture
Modelling and GIS - Livestock policy decision
system (1296) - Soil erosion risk assessment
(1323)
Tools to foster, assess, measure and
monitor sustainability of agriculture
C.A.P. reform - Bond scheme as part of the CAP
(1510)
Tools for controlling CAP measures
29
What can be ImprovedGeneral matters

• More multi-disciplinary projects in agriculture
• More NGOs and consumer representation in projects
• Clearer definitions of Sustainability and
  Consumer Demand.
• Better exploitation of Accompanying Measures.
• Attract more Demo, CA and TN proposals of good
  quality.
• Improve the interface with other Themes and Qol
  Key actions (e.g. Water in T4, KA3,)

30
Technical GapsSustainable Agriculture 5.1.1
Farming Systems and Resources

• Precision farming
• Comparison between GM crops and Traditional crops
  
• Traceability
• Agrochemical impact on soils
• Water Management/ Salination/ Pollution
• Waste management/By product usage

31
Technical GapsSustainable Agriculture 5.1.1
Plant and Animal Health

• Work on Innate Resistance
• Genetics of Plant and Animal Breeding
• Multidisciplinary approaches to meet end-users
  needs
• Integrated Pest Management
• Animal Feed quality and the feed chain
• Projects in animal welfare have generally been of
  poor quality.

32
Technical GapsRural Development 5.5

• Improvement of Policies
• Balkan Central and Eastern Countries
• Potential of information and communication
  technologies for rural development

33
Areas Open Key Action 5 SECOND YEAR
Second Call March 2000

• 5.2 Renewable Biomaterials
• 5.3.1 Multifunctional management of forests
• 5.3.2 Forestry Wood chain
• 5.4 Support for Agriculture Policy

Second Call October 2000

• 5.1.1 Sustainable agriculture
• 5.1.2 Sustainable fisheries and aquaculture
• 5.4 Support for Fisheries Policy
• 5.5 Rural Development

34
Key action VI The ageing population

• RTD objectives
• RTD into age-related illnesses and health
  problems with high morbidity
• RTD into biological, psychological, social,
  economic determinants of healthy ageing and
  mechanisms leading to disability.
• demographic and epidemiological research on
  ageing and disability trends,
• new approaches to delaying onset of disability,
  to reducing the challenge of the social and
  physical environment.
• RTD into effective and efficient delivery of
  health and social care services

• Societal aims
• to promote quality of life and healthy ageing and
  independence in old age by preventing and
  treating age-related diseases and disability, and
  their societal consequences.
• a complementary objective will be to reduce the
  need for long-term care and limit the constantly
  increasing costs of health-care systems.